Research and Breakthroughs

In the Las Madrinas Simulation Center, team members receive specialized high-fidelity pediatric medical training that supports safer care and improved outcomes for patients.

From placental research to low-field MRI, CHLA is leading the way in improving care for babies with complex congenital heart defects.

CHLA is one of just six centers in the country participating in a study that aims to identify key EEG biomarkers in Rett syndrome.

A CHLA study finds a striking disparity in families’ use—and knowledge of—AAC devices for children with autism.

A CHLA heart surgeon presented the xenotransplant results in a plenary session at the International Society for Heart and Lung Transplantation meeting.

A shortage of transplantable organs means that some babies do not get the hearts that they need in time.

Jonathan Santana, DO, and Tishya Wren, PhD, led a team of CHLA researchers who determined that children take longer to recover from non-sports-related concussions, and that age and gender also affect

A CHLA-led team received the highly selective USC NEMO Prize to support their work on a novel device to help bridge Fontan patients to transplant.

Every cancer treatment that exists for children was tested in a clinical trial. Clinical research and clinical trials are the only way to develop new and better therapies for children with cancer

Investigators led by CHLA’s Jonathan D. Santoro, MD, published a new research study that links Down syndrome Regression Disorder (DSRD) with neuroinflammation and dysfunction of the blood-brain